Member Info for MrHumble

I don't think you needed to see more than the stress on face at beginning . He was not looking forward to that

Toyin listen to fund replies

Literally no fund interest in this division

Imagine a real Q&A here? They cant even handle it at CRDA

Be -1500p per share in 7 mins

Investor meet Q&A: O Hara

Most of the question are generated from bloggers, so ll leave it for now

They might ask about royalty notes from the past in RNS's though so we could do an O Hara on that?

Just 10 of those guys and an hour with the SBTX board?

This is Artem from Rothchild & Co Redburn. I've got a question on Pharma. You've talked a lot about Pharma already, so probably mainly just plug some gaps in my question. So I want to reference back to a Pharma seminar from October, 2022, which actually took place here. When you look at this business first at the category level, so excipients, lipids, adjuvants at the same time there was a platform level view, so nucleic acid, protein delivery, small molecule. So how are you thinking about this business today? And I'm just trying to understand to what extent these items are working together. So to what extent are they overlapping to what extent your capacity is flexible to switch from one to another? Maybe just a quick colour on performance of lipids specifically. I'm not sure we talked a lot about this today and specifically you mentioned a double digit growth of Avanti since 2020. Is that including the Pfizer contract or not? And very lastly, sorry, long question. Lastly, back in 2022 you had an ambition to grow the Pharma business to £1 billion of sales. Probably a lot of things have changed since then. Have you had any plans to revisit these ambitions given what's happening to date?

Oh oh

word alert

Steve Foots: Okay, I mean we'll flash up the margin bridge in a minute, but I mean on your point about distribution,

*** just to be clear, for the avoidance of doubt****

, we're a direct selling company and anytime we acquire a business that's got a lot of distribution,

Guys can we get them to do a call with sbtx?

Hi Chatan from JP Morgan. I was just wondering on your distribution strategy, I'm a bit confused what exactly is going on because you're talking about on one hand, shutting down warehouses, rationalising your distribution network and then you're talking about taking away distributors from your ceramide business. So maybe just curious what's going on with your strategy around distribution. I remember many years ago you started insourcing from distributors. It's a debate out there whether that's really helped grow down or not, at least in terms of growth. So I'm just curious, what's the latest on the distribution strategy? And just the second question on the utilisation pricing, et cetera, cost savings, what is the end impact of this on margin? I remember a few months back we talked about 20% margin as the new run rate. If you get to 80% utilisation, is that still the case or can you do better now with these cost savings?

Sebastian Bray: Thank you. Good morning everybody. Sebastian Bray from Berenberg Bank. Can I start with one non-group utilisation rates please? I think the group has previously indicated that it was in the mid eighties prior to the pandemic striking. And if I take the indexed figures for the shared sites, so on the slides it basically implies it's somewhere in the high seventies as at the end of Q2, but this excludes the 30% or so of facilities outside for top 11 sites. And the temptation is from an analyst perspective just to say, okay, the whole group behaves as if it's in line with the big sites and ignore the remaining 30%. It sounds as if there's potentially a bit of a problem with the remainder. How is the utilisation of those other sites performing currently?

........................

You cant just pawn those lads off with assumptions lol

How do we seperate CRDA and SBTX now? All the PR systems rammed it down everyone's throats for months.

You would normally see a bigger temp bounce as crud is well hidden within the fine print at times. Must be too obvious now.

This is bad at Croda. Normally the shorters and sellers would ease off there to get more liquidity before continuing. Normally wait for the recorded call with funds for that. But it's not looking like they are willing to wait

https://x.com/YankTrain17909/status/1950197267580719374

And thats with big cost savings too.

Bored now. Back when it's exciting again, if i can find the pond of eternal life for a dip

The only thing he managed not to predict in the period, was the cash raise.

Guys, now having seen the Croda results, is it maybe a wonder why Ashman decided he was NDA'd again on June 30th?

Well, it's not like Ashman had no access to the facts, directly or indirectly

awful